Scarica l'app Stockscreener
2.265
2.49%
0.055
Dopo l'orario di chiusura:
2.27
0.005
+0.22%
Precedente Chiudi:
$2.21
Aprire:
$2.18
Volume 24 ore:
16,292
Relative Volume:
0.52
Capitalizzazione di mercato:
$1.50M
Reddito:
$17.59M
Utile/perdita netta:
$-13.12M
Rapporto P/E:
-0.0105
EPS:
-215.5494
Flusso di cassa netto:
$-8.60M
1 W Prestazione:
-22.96%
1M Prestazione:
-47.93%
6M Prestazione:
-90.74%
1 anno Prestazione:
-88.38%
Intervallo 1D:
$2.11
$2.30
Intervallo di 1 settimana:
$1.95
$2.90
Portata 52W:
$1.95
$168.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Nome
22nd Century Group, Inc.
Settore
Industria
Telefono
716-270-1523
Indirizzo
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
2.265 | 1.50M | 17.59M | -13.12M | -8.60M | -215.55 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-21 | Iniziato | Alliance Global Partners | Buy |
| 2022-06-15 | Iniziato | Craig Hallum | Buy |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-23 | Iniziato | Cowen | Outperform |
| 2017-10-16 | Reiterato | Chardan Capital Markets | Buy |
| 2016-08-11 | Reiterato | Chardan Capital Markets | Buy |
Mostra tutto
22nd Century Group, Inc. Borsa (XXII) Ultime notizie
Death Cross: Does 22nd Century Group Inc outperform in volatile marketsMarket Volume Summary & Technical Entry and Exit Alerts - baoquankhu1.vn
XXII PE Ratio & Valuation, Is XXII Overvalued - Intellectia AI
XXII Technical Analysis | Trend, Signals & Chart Patterns | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
XXII Should I Buy - Intellectia AI
22nd Century (XXII) registers $250M shelf; Needham ATM up to $1.84M - Stock Titan
Income Plays: Is ARDT stock a buy or sellTrade Signal Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Jobs Data: What are the future prospects of 22nd Century Group Inc2026 Buyback Activity & Daily Technical Forecast Reports - baoquankhu1.vn
Will 22nd Century Group Inc outperform tech stocksWeekly Stock Recap & Low Volatility Stock Suggestions - baoquankhu1.vn
22nd Century Group Achieves Debt-Free Status to Fuel Growth Strategy - AD HOC NEWS
XXII (22nd Century Group) Debt-to-EBITDA : -0.15 (As of Dec. 2025) - GuruFocus
Tag: EBITDA - Tobacco Reporter
22nd Century Group Inc (XXII) Q4 2025 Earnings Call Highlights: Strategic Shift Fuels Growth Amidst Challenges - gurufocus.com
22nd Century Group Reports Q4 and Full Year 2025 Results: VLN® Expansion, Higher Margins, and Debt-Free Growth - Minichart
22nd Century Group Inc (XXII) Q4 2025 Earnings Call Highlights: Strategic Shift Fuels Growth ... By GuruFocus - Investing.com Canada
22nd Century Group, Inc. 2025 Annual Report: VLN Reduced Nicotine Cigarettes, Risks, and Business Overview - Minichart
22nd Century Debt-Free in Announcing 2025 Results - Tobacco Reporter
22nd Century Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Earnings call transcript: 22nd Century Group’s Q4 2025 shows strategic shift - Investing.com Australia
XXII: Transitioned to growth in 2025, launching VLN products and strengthening financials - TradingView
XXII Reports Q4 Revenue Decline with Strategic Adjustments in Fo - GuruFocus
22nd Century Group (XXII) Reports Q4 Revenue Decline and Misses Estimates - GuruFocus
22nd Century Group reports Q4 revenue $3.5M, exits 2025 debt-free with $7.1M cash - TradingView
22nd Century (NASDAQ: XXII) 2025 revenue drops to $17.6M as mix shifts - Stock Titan
22nd Century Group reports $17.59M revenue and $(71.26) EPS; narrower net loss - TradingView
22nd Century Group Q4 losses narrow on market expansion, improved margins - TradingView
Going concern risk and VLN nicotine strategy at 22nd Century (NASDAQ: XXII) - Stock Titan
Debt-free after a reset, 22nd Century expands low-nicotine push - Stock Titan
22nd Century Group Inc (XXII) Q4 2025: Everything You Need To Kn - GuruFocus
XXII Q4'25 Earnings: EPS estimate is (2.10) USD - TradingView
22nd Century Group, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
22nd Century (XXII) files registration for 33.87M underlying shares from Series B deal - Stock Titan
22nd Century Group Inc expected to post a loss of $7.35 a shareEarnings Preview - TradingView
XXII Q4'25 Earnings: revenue estimate is 4.05M USD - TradingView
22nd Century Group to Announce Q4, FY25 Results March 26 - Tobacco Reporter
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 - 富途牛牛
22nd Century's March 26 webcast will detail 2025 results, 2026 plans - Stock Titan
22nd Century Group, Inc. Announces Series B Preferred Stock and Warrant Offering Under S-3 Registration Statement - Minichart
22nd Century Announces Series B Preferred Stock Financing - TipRanks
22nd Century Group Launches Up to $20 Million Series B Preferred Offering With Warrants; $16 Million Initial Close - TradingView
22nd Century Group (NASDAQ: XXII) launches $20M Series B preferred and warrant financing - stocktitan.net
22nd Century (XXII) Share Price Forecast & Price Target - Investing.com UK
Aug Setups: Does 22nd Century Group Inc stock have upside surprise potential2026 WrapUp & Target Return Focused Stock Picks - baoquankhu1.vn
22nd Century Group, Inc.: Fundamental Analysis and Financial Ratings | | US90137F4000 - marketscreener.com
22nd Century Group, Inc. Financial Disclosures & SEC Filings - TradingView
Earnings Report: Is 22nd Century Group Inc stock risky to hold nowJuly 2025 PreEarnings & Technical Entry and Exit Tips - baoquankhu1.vn
Buyback Watch: Will 22nd Century Group Inc outperform tech stocks2025 Volatility Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
22nd Century Group developing 100mm very low nicotine cigarette - MSN
Aug Macro: Is 22nd Century Group Inc benefiting from interest rate changesMarket Sentiment Summary & AI Enhanced Trading Signals - baoquankhu1.vn
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap - 2Firsts
22nd Century Group Pivots to Proprietary VLN Products Amid Nasdaq Compliance Efforts () - aktiencheck.de
22nd Century (XXII) Gains Momentum with VLN Low Nicotine Cigaret - GuruFocus
22nd Century Group, Inc. Azioni (XXII) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):